Home | Sitemap | Search | ContactA- A A+
   
 
    Public Member Support us  
 

IBCSG 48-14 POSITIVE 

A study evaluating the pregnancy outcomes and safety of interrupting endocrine therapy for young women with endocrine responsive breast cancer who desire pregnancy.

DESIGN

please click on the picture to see a larger version

Results & Publications

Publications

Study Chair
Dr. Olivia Pagani, Dr. Ann Partridge, Dr. Hatem Azim, Dr. Fedro Peccatori

Statistician
Dr. Zhuoxin Sun

Lead Trial Coordinator
Holly Shaw

Trial Coordinator
Poonam Jani

Data Manager
Poonam Jani, Susan Fischer

Trial Monitors
Giuseppe Achille, Daniela Celotto, Carmen Comune, Magdalena Sánchez-Hohl, Lionel Nobs, Mariana Pardo Contreras,

IBCSG Coordinating Center Bern, Switzerland

IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 511 94 00
Fax: +41 31 511 94 01
Email: positive-monitoring@ibcsg.org

Date of Activation
July 3, 2014

Targeted Accrual
500


News

23.03.2019:
The next IBCSG Annual Meeting will take place in Vienna Austria on March 23 and 24, 2019.       

09.09.2018:
9.9.2018 - RACE FOR LIFE, Bundesplatz Bern

08.08.2018:
Clinical Trials

All News

 
  Print